Stay updated on LN-144 Clinical Trial in Metastatic Melanoma
Sign up to get notified when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.

Latest updates to the LN-144 Clinical Trial in Metastatic Melanoma page
- CheckyesterdayChange DetectedA new Revision: v3.5.4 label has been added, replacing Revision: v3.5.3 on the page. This indicates a software or content update for the page but does not alter the study data or its presentation.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe Study Documents list now includes Revision: v3.5.3, while Revision: v3.5.2 has been removed. This indicates an update to the official protocol version available for review, reflecting version control rather than changes to study content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision numbers for the study protocol documents were updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.0%

- Check52 days agoChange DetectedSite location was updated from Napoli, Italy, 80131 to Naples, Italy, 80131. The Study Plan adds a 'Maximum 60 months' time frame for outcomes and expands the Safety Profile to specify incidence, seriousness, relationship to treatment, and characteristics of treatment-emergent adverse events.SummaryDifference0.3%

- Check59 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed. This update appears to be a platform version change rather than a modification to study content or user-facing information.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.SummaryDifference0.0%

Stay in the know with updates to LN-144 Clinical Trial in Metastatic Melanoma
Enter your email address, and we'll notify you when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.